Pain, Depression Greatly Impact Quality of Life in Patients With MOGAD-Related Pain
Pain and depression have a significant impact on quality of life (QoL) and activities of daily living (ADL) in patients with Myelin oligodendrocyte glycoprotein-antibody (MOG-ab)-associated disease (MOGAD), but pain and depression remain insufficiently controlled in these patients, according to study findings published in the European Journal of Neurology. This exploratory cross-sectional study included 43 patients […]
Pain, Depression Greatly Impact Quality of Life in Patients With MOGAD-Related Pain Read More »